<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34023955</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.</ArticleTitle><Pagination><StartPage>393</StartPage><EndPage>398</EndPage><MedlinePgn>393-398</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05333-9</ELocationID><Abstract><AbstractText>The aim of the article was to evaluate the role of electromyography and the value of Awaji criteria for the diagnosis of ALS in the early stage. The study involves 48 patients (27 male and 21 females from 41 to 84 years old) who went to Bach Mai Hospital and Dong Do Clinic in Hanoi and were diagnosed with ALS according to Awaji criteria. All patients underwent clinical examination for ALS. The patients were examined for nerve conduction (motor and sensory conduction) using needle electromyography (EMG). Upper motor neuron (UMN) signs and lower motor neuron (LMN) signs were most common in the cervical region (89.58%), the lumbosacral region (70.83%), and the bulbar region (56.25%). The sensory nerve conduction was normal. The spontaneous activities (fasciculation, fibrillation, positive wave) accounted for more than 50% in all 4 regions: bulbar, cervical, thoracic, and lumbosacral regions. The abnormality of both clinical and electrodiagnosis was seen in the cervical region (87.5%) and lumbosacral one (70.83%) while the bulbar region and thoracic one usually had abnormal electrodiagnosis before clinical. There were 60.42% of patients with "definite ALS" by Awaji criteria. It allowed to make an earlier diagnosis cause the sensitivity of Awaji criteria (93.75%) was higher than the revised El Escorial criteria (85.42%) (p &lt; 0.05). The needle EMG makes it possible to detect the early-stage symptoms of ALS in a situation where there are no clinical manifestations, especially in bulbar and thoracic regions.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Nguyen</LastName><ForeName>Tuan</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7256-1224</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Bach Mai Hospital, Hanoi, Vietnam. nguyenvantuan403@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Tuan Anh</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Radiology Center, Bach Mai Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology Department, Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Hinh Thi</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004568" MajorTopicYN="N">Electrodiagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005207" MajorTopicYN="N">Fasciculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014744" MajorTopicYN="N" Type="Geographic">Vietnam</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Awaji criteria</Keyword><Keyword MajorTopicYN="N">Electromyography</Keyword><Keyword MajorTopicYN="N">Revised El Escorial criteria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>23</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34023955</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05333-9</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05333-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foster LA, Salajegheh MK (2019) Motor neuron disease: pathophysiology, diagnosis, and management. Am J Med 132(1):32&#x2013;37. https://doi.org/10.1016/j.amjmed.2018.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2018.07.012</ArticleId><ArticleId IdType="pubmed">30075105</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2016 Motor Neuron Disease Collaborators (2018) Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(12):1083&#x2013;1097. https://doi.org/10.1016/S1474-4422(18)30404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Shtok VN, Levin OS (2006) Reference book on formulation of clinical diagnosis of nervous system diseases. Meditsinskoe informatsionnoe agentstvo, Moscow</Citation></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, van den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15(11):1182&#x2013;1194. https://doi.org/10.1016/S1474-4422(16)30199-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10(11):661&#x2013;670. https://doi.org/10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D, Talbot K, Turner MR (2014) Advances in motor neurone disease. J R Soc Med 107(1):14&#x2013;21. https://doi.org/10.1177/0141076813511451</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0141076813511451</ArticleId><ArticleId IdType="pubmed">24399773</ArticleId><ArticleId IdType="pmc">3883149</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B (2016) Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol (Paris) 172(1):37&#x2013;45. https://doi.org/10.1016/j.neurol.2015.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.11.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston DC, Shapiro BE (2013) Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations. Elsevier Saunders, London, New York</Citation></Reference><Reference><Citation>Johnston CA, Stanton BR, Turner MR, Gray R, Blunt AHM, Butt D, Ampong MA, Shaw CE, Leigh PN, Al-Chalabi A (2006) Amyotrophic lateral sclerosis in an urban setting: a population based on study of inner-city London. J Neurol 253(12):1642&#x2013;1643. https://doi.org/10.1007/s00415-006-0195-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0195-y</ArticleId><ArticleId IdType="pubmed">17219036</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedev YV, Kolganova MA, Sas OA, Komarov TN, Fisher EN, Shohin IE, Ammour YI (2020) Immunogenicity assessment of pegfilgrastim in patients with breast cancer. Drug Develop Registr 9(2):140&#x2013;144. https://doi.org/10.33380/2305-2066-2020-9-2-140-144</Citation><ArticleIdList><ArticleId IdType="doi">10.33380/2305-2066-2020-9-2-140-144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J (2015) A revision of the El Escorial criteria&#x2014;2015. Amyotroph Lateral Scler Frontotemporal Degener 16(5-6):291&#x2013;292. https://doi.org/10.3109/21678421.2015.1049183</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119(3):497&#x2013;503. https://doi.org/10.1016/j.clinph.2007.09.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Statland JM, Barohn RJ, McVey AL, Katz JS, Dimachkie MM (2015) Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis. Neurol Clin 33(4):735&#x2013;748. https://doi.org/10.1016/j.ncl.2015.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.006</ArticleId><ArticleId IdType="pubmed">26515618</ArticleId><ArticleId IdType="pmc">4629510</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(3):847&#x2013;852. https://doi.org/10.1093/brain/awr351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId><ArticleId IdType="pmc">3286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, Nakano I, Shaw P, Shefner J, van den Berg LH, Ludolph A, The WFN Research Group on ALS/MND (2015) The El Escorial criteria: strengths and weaknesses. Amyotroph Lateral Scler Frontotemporal Degener 16(1-2):1&#x2013;7. https://doi.org/10.3109/21678421.2014.964258</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.964258</ArticleId><ArticleId IdType="pubmed">25482030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer M, Buerger M, Berlit P (2010) Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 112(2):103&#x2013;105. https://doi.org/10.1016/j.clineuro.2009.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2009.10.014</ArticleId><ArticleId IdType="pubmed">19931253</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce NC, Carter GT (2013) Electrodiagnosis in amyotrophic lateral sclerosis. PM R 5(50):89&#x2013;95. https://doi.org/10.1016/j.pmrj.2013.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2013.03.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieva EI (2020) Modern technologies of controlled release of biologically active substances in pharmaceutical research and development (review). Drug Development &amp; Registration 9(2):56&#x2013;66. https://doi.org/10.33380/2305-2066-2020-9-2-56-66</Citation><ArticleIdList><ArticleId IdType="doi">10.33380/2305-2066-2020-9-2-56-66</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J (2015) Amyotrophic Lateral Sclerosis (ALS) and related motor neuron diseases: an overview. Neurodiagn J 55(3):180&#x2013;194. https://doi.org/10.1080/21646821.2015.1075181</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21646821.2015.1075181</ArticleId><ArticleId IdType="pubmed">26630810</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Jiang JY, Lu FZ, Xia XL, Wang LX, Zheng CJ (2014) Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy. BMC Musculoskelet Disord 15(1):349. https://doi.org/10.1186/1471-2474-15-349</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-15-349</ArticleId><ArticleId IdType="pubmed">25319248</ArticleId><ArticleId IdType="pmc">4216382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez BA (2015) Amyotrophic lateral sclerosis can mimic orthopedic disease-cases report. OAJNN 1(1):55552. https://doi.org/10.19080/OAJNN.2015.01.555552</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/OAJNN.2015.01.555552</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, Misawa S, Kanai K, Shibuya K, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Nakagawa M, Kuwabara S (2012) Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol 123(2):382&#x2013;385. https://doi.org/10.1016/j.clinph.2011.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.05.030</ArticleId><ArticleId IdType="pubmed">21764635</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Leigh PN (2000) Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol 13(4):397&#x2013;405. https://doi.org/10.1097/00019052-200008000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019052-200008000-00006</ArticleId><ArticleId IdType="pubmed">10970056</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>